Department of Urology, Stanford University School of Medicine, Stanford, CA, USA.
Department of Obstetrics and Gynecology, Stanford University School of Medicine, Stanford, CA, USA.
Andrology. 2021 Jan;9(1):245-252. doi: 10.1111/andr.12908. Epub 2020 Oct 8.
Low semen quality often obligates the use of assisted reproductive technology; however, the association between semen quality and assisted reproductive technology outcomes is uncertain.
To further assess the impact of semen quality on assisted reproductive technology outcomes.
A retrospective cohort study was carried out at a single academic reproductive medicine center (January 2012-December 2018). Patients undergoing at least one assisted reproductive technology cycle utilizing freshly ejaculated spermatozoa from the male partner were included. We assessed the association between semen quality (as stratified based on WHO 5th edition criteria), paternal age (< or ≥40), and reproductive/perinatal outcomes. To evaluate the differences in assisted reproductive technology outcomes by semen parameters and age, generalized estimating equations were applied for rates of fertilization, pregnancy, implantation, miscarriage, live birth, blast formation, gestational age, and normal embryo biopsy.
A total of 2063 couples were identified who underwent 4517 assisted reproductive technology cycles. Average ages of the male and female partners were 39.8 and 37.7, respectively. Lower pregnancy rates were observed in cycles with lower sperm motility (ie <40%; 39.9% vs 44.1%) and total motile count (ie <9 million; 38.3% vs 43.5%). When examining only cycles utilizing Intracytoplasmic Sperm Injection, only a lower motility count was associated with a decline in pregnancy rate (39.1% vs 44.9%). No association was identified between semen quality and gestational age or birth weight. Paternal age was not associated with ART outcomes. However, among assisted reproductive technology cycles in women <40, aneuploidy rate was higher for older men (P < .001). In cycles with women >40, no association between aneuploidy and male age was identified.
Sperm motility is associated with pregnancy rates, while other semen parameters are not. In cycles in women <40, paternal age is associated with embryo aneuploidy rate.
Paternal factors are associated with assisted reproductive technology outcomes, and future studies should explore mechanisms by which semen quality is associated with assisted reproductive technology outcomes.
精液质量低常迫使人们使用辅助生殖技术;然而,精液质量与辅助生殖技术结局之间的关系尚不确定。
进一步评估精液质量对辅助生殖技术结局的影响。
本研究为单中心回顾性队列研究,于 2012 年 1 月至 2018 年 12 月在一家学术型生殖医学中心开展。纳入至少接受过一次辅助生殖技术周期治疗的夫妇,这些夫妇的男方提供了新鲜射出的精子。我们根据世界卫生组织第五版标准对精液质量(分层标准为精液质量)、父亲年龄(<40 岁或≥40 岁)与生殖/围产结局进行了相关性评估。为了评估精液参数和年龄对辅助生殖技术结局的影响,我们采用了广义估计方程来评估受精率、妊娠率、种植率、流产率、活产率、胚泡形成率、胎龄和正常胚胎活检率的差异。
共纳入 2063 对夫妇,他们共接受了 4517 个辅助生殖技术周期。男方和女方的平均年龄分别为 39.8 岁和 37.7 岁。较低的精子活力(即<40%;39.9%比 44.1%)和总活动精子计数(即<900 万;38.3%比 43.5%)与较低的妊娠率相关。当仅检查采用胞浆内单精子注射的周期时,只有较低的精子活力计数与妊娠率下降相关(39.1%比 44.9%)。精液质量与胎龄或出生体重无关。然而,在年龄<40 岁的女性的辅助生殖技术周期中,高龄男性的胚胎非整倍体率更高(P<.001)。在年龄>40 岁的女性的辅助生殖技术周期中,男性年龄与胚胎非整倍体率之间无相关性。
精子活力与妊娠率相关,而其他精液参数则与妊娠率无关。在年龄<40 岁的女性的辅助生殖技术周期中,父亲年龄与胚胎非整倍体率相关。
父亲因素与辅助生殖技术结局相关,未来的研究应探讨精液质量与辅助生殖技术结局相关的机制。